# CareTrust REIT, Inc.: financial statements, quarterly

CTRE · NYSE · CIK 1590717 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctre.md) · [Financials](/companies/ctre/financials.md) · [Filings](/companies/ctre/filings.md) · [Insiders](/companies/ctre/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ctre/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [55.9](/filings/0001628280-24-044095.md) | [(158) d](/filings/0001628280-26-007664.md) | [63.1](/filings/0001628280-25-021524.md) | [68.9](/filings/0001628280-25-038321.md) | [77.4](/filings/0001628280-25-049531.md) | [(209) d](/filings/0001628280-26-007664.md) | [0.0](/filings/0001628280-26-032118.md) | [0.0](/filings/0001628280-26-054284.md) | [132](/filings/0001628280-25-049531.md) | [(340) d](/filings/0001628280-26-007664.md) | [3.9](/filings/0001628280-26-032118.md) | [4.6](/filings/0001628280-26-054284.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [11.8](/filings/0001628280-24-044095.md) | [8.3 d](/filings/0001628280-26-007664.md) | [8.2](/filings/0001628280-25-021524.md) | [8.7](/filings/0001628280-25-038321.md) | [8.3](/filings/0001628280-25-049531.md) | [5.1 d](/filings/0001628280-26-007664.md) | [6.7](/filings/0001628280-26-032118.md) | [13.0](/filings/0001628280-26-054284.md) | [12.6](/filings/0001628280-25-049531.md) | [11.4 d](/filings/0001628280-26-007664.md) | [11.2](/filings/0001628280-26-032118.md) | [15.3](/filings/0001628280-26-054284.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0001628280-25-038321.md) | [0.0](/filings/0001628280-25-049531.md) | [0.0 d](/filings/0001628280-26-007664.md) | [0.0](/filings/0001628280-26-032118.md) | [1.0](/filings/0001628280-26-054284.md) | [2.1](/filings/0001628280-25-049531.md) | [1.9 d](/filings/0001628280-26-007664.md) | [2.3](/filings/0001628280-26-032118.md) | [2.5](/filings/0001628280-26-054284.md) |
| Net income | $m | [8.7](/filings/0001628280-24-044095.md) | [26.3 d](/filings/0001628280-26-007664.md) | [28.7](/filings/0001628280-25-021524.md) | [10.8](/filings/0001628280-25-038321.md) | [33.4](/filings/0001628280-25-049531.md) | [52.1 d](/filings/0001628280-26-007664.md) | [65.8](/filings/0001628280-26-032118.md) | [68.5](/filings/0001628280-26-054284.md) | [74.9](/filings/0001628280-25-049531.md) | [111 d](/filings/0001628280-26-007664.md) | [80.2](/filings/0001628280-26-032118.md) | [89.0](/filings/0001628280-26-054284.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001628280-24-044095.md) | not reported | [0.22](/filings/0001628280-25-021524.md) | [0.07](/filings/0001628280-25-038321.md) | [0.21](/filings/0001628280-25-049531.md) | not reported | [0.35](/filings/0001628280-26-032118.md) | [0.35](/filings/0001628280-26-054284.md) | [0.35](/filings/0001628280-25-049531.md) | not reported | [0.36](/filings/0001628280-26-032118.md) | [0.38](/filings/0001628280-26-054284.md) |
| Basic EPS | $ per share | [0.08](/filings/0001628280-24-044095.md) | not reported | [0.22](/filings/0001628280-25-021524.md) | [0.07](/filings/0001628280-25-038321.md) | [0.21](/filings/0001628280-25-049531.md) | not reported | [0.35](/filings/0001628280-26-032118.md) | [0.36](/filings/0001628280-26-054284.md) | [0.35](/filings/0001628280-25-049531.md) | not reported | [0.36](/filings/0001628280-26-032118.md) | [0.38](/filings/0001628280-26-054284.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.5](/filings/0001628280-23-038221.md) | [294](/filings/0001628280-25-005118.md) | [451](/filings/0001628280-24-019995.md) | [495](/filings/0001628280-24-034247.md) | [377](/filings/0001628280-24-044095.md) | [214](/filings/0001628280-26-007664.md) | [26.5](/filings/0001628280-25-021524.md) | [306](/filings/0001628280-25-038321.md) | [712](/filings/0001628280-25-049531.md) | [198](/filings/0001628280-26-054284.md) | [223](/filings/0001628280-26-032118.md) | [47.6](/filings/0001628280-26-054284.md) |
| Total assets | $m | [1,768](/filings/0001628280-23-038221.md) | [2,085](/filings/0001628280-25-005118.md) | [2,348](/filings/0001628280-24-019995.md) | [2,699](/filings/0001628280-24-034247.md) | [2,921](/filings/0001628280-24-044095.md) | [3,437](/filings/0001628280-26-007664.md) | [3,884](/filings/0001628280-25-021524.md) | [4,657](/filings/0001628280-25-038321.md) | [5,089](/filings/0001628280-25-049531.md) | [5,148](/filings/0001628280-26-054284.md) | [5,237](/filings/0001628280-26-032118.md) | [5,929](/filings/0001628280-26-054284.md) |
| Total liabilities | $m | [657](/filings/0001628280-23-038221.md) | [666](/filings/0001628280-25-005118.md) | [672](/filings/0001628280-24-019995.md) | [753](/filings/0001628280-24-034247.md) | [496](/filings/0001628280-24-044095.md) | [508](/filings/0001628280-26-007664.md) | [936](/filings/0001628280-25-021524.md) | [1,332](/filings/0001628280-25-038321.md) | [1,072](/filings/0001628280-25-049531.md) | [1,089](/filings/0001628280-26-054284.md) | [1,083](/filings/0001628280-26-032118.md) | [1,416](/filings/0001628280-26-054284.md) |
| Long-term debt | $m | [595](/filings/0001628280-23-038221.md) | [596](/filings/0001628280-25-005118.md) | [596](/filings/0001628280-24-019995.md) | [671](/filings/0001628280-24-034247.md) | [397](/filings/0001628280-24-044095.md) | [397](/filings/0001628280-26-007664.md) | [822](/filings/0001628280-25-021524.md) | [1,155](/filings/0001628280-25-038321.md) | [894](/filings/0001628280-25-049531.md) | [894](/filings/0001628280-26-054284.md) | [895](/filings/0001628280-26-032118.md) | [1,205](/filings/0001628280-26-054284.md) |
| Shareholders' equity | $m | [1,110](/filings/0001628280-23-038221.md) | [1,417](/filings/0001628280-25-005118.md) | [1,674](/filings/0001628280-24-019995.md) | [1,944](/filings/0001628280-24-034247.md) | [2,422](/filings/0001628280-24-044095.md) | [2,908](/filings/0001628280-26-007664.md) | [2,927](/filings/0001628280-25-021524.md) | [3,301](/filings/0001628280-25-038321.md) | [3,994](/filings/0001628280-25-049531.md) | [4,035](/filings/0001628280-26-054284.md) | [4,132](/filings/0001628280-26-032118.md) | [4,491](/filings/0001628280-26-054284.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [45.1 d](/filings/0001628280-24-044095.md) | [42.7 d](/filings/0001628280-26-007664.md) | [48.8](/filings/0001628280-25-021524.md) | [53.0 d](/filings/0001628280-25-038321.md) | [67.2 d](/filings/0001628280-25-049531.md) | [75.2 d](/filings/0001628280-26-007664.md) | [71.4](/filings/0001628280-26-032118.md) | [101 d](/filings/0001628280-26-054284.md) | [101 d](/filings/0001628280-25-049531.md) | [121 d](/filings/0001628280-26-007664.md) | [90.4](/filings/0001628280-26-032118.md) | [135 d](/filings/0001628280-26-054284.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [27.8 d](/filings/0001628280-24-044095.md) | [32.4 d](/filings/0001628280-26-007664.md) | [36.5](/filings/0001628280-25-021524.md) | [41.2 d](/filings/0001628280-25-038321.md) | [44.7 d](/filings/0001628280-25-049531.md) | [49.7 d](/filings/0001628280-26-007664.md) | [54.4](/filings/0001628280-26-032118.md) | [63.1 d](/filings/0001628280-26-054284.md) | [67.1 d](/filings/0001628280-25-049531.md) | [74.8 d](/filings/0001628280-26-007664.md) | [74.8](/filings/0001628280-26-032118.md) | [88.5 d](/filings/0001628280-26-054284.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [96.6](/filings/0001628280-23-038221.md) | [99.1](/filings/0001628280-24-019995.md) | [99.1](/filings/0001628280-24-034247.md) | [104](/filings/0001628280-24-044095.md) | [133](/filings/0001628280-25-021524.md) | [145](/filings/0001628280-25-038321.md) | [160](/filings/0001628280-25-049531.md) | [187](/filings/0001628280-26-032118.md) | [193](/filings/0001628280-26-054284.md) | [212](/filings/0001628280-25-049531.md) | [224](/filings/0001628280-26-032118.md) | [234](/filings/0001628280-26-054284.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 236,293,199 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054284.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.